UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the US.

Siemens (0P6M – Research Report) received a Hold rating and a €240.00 price target from Deutsche Bank analyst Gael De-Bray today. The ...

Brokers say investors, including U.S. and European distressed asset managers, are more interested in exposure to Russia's ...

In a report released on March 21, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...